ASN applauds the U.S. Food and Drug Administration for amending the emergency use authorizations for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, including kidney transplant recipients.
ASN’s annual Board Review Course & Update (BRCU) is an important educational activity for fellows preparing for initial board certification, reaching approximately 400 in-person/live learners and 400 online learners annually in a "normal" year. Due to the uncertainties and challenges relative to COVID-19, the BRCU 2020 in-person event was cancelled, and BRCU 2021 was offered for the first time as a fully virtual event.
Given that hospital rankings may present limited information and fail to adequately assess relevant factors (such as social determinants of health, health disparities, and health inequities), this guide offers some context about how they are calculated, as well as their transparency, comprehensiveness, utility, and limits. Also included is a list kidney disease resources for patients and family members.
ASN and other groups are urging Congress and the Administration to make a critical investment in the nation’s health care delivery system by maintaining the 3.75% increase to the CF through at least calendar years 2022 and 2023.
ASN Executive Vice President Tod Ibrahim and ASN Regulatory and Quality Officer David White offer insights about federal funding for kidney research, visas for international medical graduates, and the Equality Act.
During Kidney Week, STARS participants attend poster sessions, “Meet the Expert” panel discussions, and networking opportunities with nephrology leaders. STARS participants are grouped by special interest and paired with mentors who offer guidance during the event.
In a recent letter to the White House Office of Management and Budget, ASN offered an overview of the current state of inequities and disparities in kidney diseases and emphasized four areas for consideration when evaluating agency policies and actions.
Investigators discovered that kidney failure symptoms tended to increase or remain unchanged between transplant evaluation and transplantation; however, three months after transplantation, 9 of 11 symptoms lessened.
As the 2021-2022 interviewing and recruitment season gets underway, ASN continues to strongly encourage nephrology fellowship programs to conduct all interviews with applicants during the recruitment cycle remotely. Health, safety, and equity are key factors of this best practice.